Mantoux tuberculin skin test
The Mantoux tuberculin skin test is a skin test for tuberculosis exposure in Microbiology. Purified protein derivative is injected intradermally, then induration is measured 48 to 72 hours later.
What is the Mantoux tuberculin skin test?
The Mantoux tuberculin skin test is a microbiology diagnostic test used to screen for exposure to Mycobacterium tuberculosis. It works by injecting purified protein derivative, or PPD, just under the skin and checking for a delayed immune reaction 48 to 72 hours later.
The reaction is not a random skin irritation. It depends on cell-mediated immunity, especially memory T cells that recognize TB antigens if the person has seen them before. If those immune cells are already primed, they release signals that recruit more immune cells to the site, which creates a firm raised swelling called induration.
That delayed timing matters. A positive result is not measured right away because the test is looking for a type IV hypersensitivity response, not an immediate allergic reaction. You measure the hardness of the bump in millimeters, not the redness around it, since erythema can happen for other reasons and is much less reliable.
In Microbiology, this test shows up as part of the bigger story of tuberculosis diagnosis. A positive Mantoux test suggests infection or previous exposure, but it does not tell you whether the person has latent TB infection or active disease. That is why follow-up testing, such as a chest X-ray or sputum culture, is often needed if the result is positive.
The test also has built-in limitations that matter when you interpret it. Someone who received the BCG vaccine may react even without true TB infection, and exposure to some non-tuberculosis mycobacteria can also cause a false positive. On the other hand, an immunocompromised person or someone infected very recently may not mount a strong enough response yet, which can give a false negative.
So when you see Mantoux in a microbiology chapter, think of it as an immune memory check, not a direct germ count. It is a simple skin procedure, but the result depends on host immunity, timing, and whether the person has been exposed to related mycobacteria before.
Why the Mantoux tuberculin skin test matters in MICROBIO
The Mantoux tuberculin skin test connects immunology to respiratory microbiology in a very practical way. It shows how the body can remember an infection even when the organism is not easy to detect directly at the skin site.
It also helps you separate screening from confirmation. A positive Mantoux result is a clue, not a final diagnosis. In TB cases, you have to think about the next step, like chest imaging or sputum culture, because microbiology often asks you to move from exposure evidence to evidence of active disease.
This term is also a good way to practice interpreting false positives and false negatives. If a patient has had the BCG vaccine, the test may react even without tuberculosis. If the patient is immunosuppressed, the immune response may be too weak to form obvious induration. That kind of reasoning comes up often in lab reports, case questions, and class discussions about infectious disease screening.
Finally, the test helps you understand why TB diagnosis is not just about the bacterium. Host immunity, vaccination history, and timing after exposure all change the result. That makes Mantoux a useful bridge between microbial pathogenesis and the immune response.
Keep studying MICROBIO Unit 22
Official unit cheatsheet
open one-pagerHow the Mantoux tuberculin skin test connects across the course
Tuberculosis (TB)
Mantoux is used to look for exposure to the organism that causes tuberculosis. In a TB case, the skin test is one clue, but it does not tell you whether the infection is active in the lungs or hidden in the body. That is why TB workups often continue with imaging or sputum testing after a positive reaction.
Latent TB Infection (LTBI)
A positive Mantoux test often shows up in latent TB infection, where the immune system has contained the bacteria but the person does not have obvious disease symptoms. This is where the test is most useful in screening, because it can flag infection before the organism causes active illness or spreads further.
Purified Protein Derivative (PPD)
PPD is the substance injected during the Mantoux test. It contains TB antigens that trigger a delayed immune response in someone who has been exposed before. If you confuse the test with the injected material, remember that Mantoux is the procedure and PPD is the antigen mixture used inside it.
BCG vaccine
BCG vaccination can make the Mantoux test harder to interpret because it may cause a false positive. In microbiology questions, that means you have to think about the person’s vaccine history before treating a positive skin test as proof of TB infection. The same idea applies when non-tuberculosis mycobacteria are involved.
Is the Mantoux tuberculin skin test on the MICROBIO exam?
A quiz or case study might give you a patient with a raised bump after PPD injection and ask you what the result means. Your job is to identify induration as the measured sign, not redness, and to explain that the test suggests TB exposure rather than proving active disease. If the case mentions recent infection, immunosuppression, or BCG vaccination, you should use that detail to predict a false negative or false positive. In a lab or discussion prompt, you may also be asked what comes next after a positive result, which is usually follow-up testing like a chest X-ray or sputum culture.
The Mantoux tuberculin skin test vs BCG vaccine
These are easy to mix up because both are connected to tuberculosis, but they are not the same thing. The Mantoux tuberculin skin test is a diagnostic skin test, while BCG is a vaccine used for protection in some settings. BCG history can affect how you read the Mantoux result, which is why the two often get discussed together.
Key things to remember about the Mantoux tuberculin skin test
The Mantoux tuberculin skin test checks for immune memory to Mycobacterium tuberculosis by injecting PPD into the skin.
You read the test by measuring induration in millimeters after 48 to 72 hours, not by measuring redness.
A positive result means exposure or infection is possible, but it does not tell you whether TB is latent or active.
BCG vaccination, non-tuberculosis mycobacteria, recent infection, and weak immunity can all change how the test looks.
In microbiology, a positive Mantoux test often leads to follow-up tests such as chest X-ray or sputum culture.
Frequently asked questions about the Mantoux tuberculin skin test
What is the Mantoux tuberculin skin test in Microbiology?
It is a tuberculosis screening test that uses an intradermal injection of purified protein derivative, or PPD. After 48 to 72 hours, the site is checked for induration, which reflects a delayed immune response to TB exposure. It is a screening tool, not a final diagnosis of active disease.
What does a positive Mantoux test mean?
A positive result usually means the person has been exposed to Mycobacterium tuberculosis or has TB infection. It does not prove active tuberculosis on its own. In microbiology, a positive result often needs follow-up with chest imaging or sputum testing.
Why is induration measured instead of redness?
Induration is the firm, raised swelling caused by the immune response, and it is more reliable than redness. Erythema can happen for lots of reasons and does not track TB exposure as well. That is why the skin test is read by palpation and measurement of the bump.
Can the Mantoux test be wrong?
Yes. BCG vaccination and exposure to other mycobacteria can cause false positives. False negatives can happen if the infection is very recent or if the person has a weakened immune system, because the delayed response may be too small to measure.